SCHEMBL18106900

SCHEMBL18106900

O=C(O)Nc1nc2c([N+](=O)[O-])cccc2[nH]1.c1ccc(C2CC2)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 8/20 0.48
RAB9A P51151 6/20 0.48
NPC1 O15118 5/20 0.47
IRAK4 Q9NWZ3 3/20 0.43
PKN1 Q16512 1/20 0.43
PKN2 Q16513 1/20 0.43
MAOB P27338 2/20 0.42
ADORA2A P29274 2/20 0.42
ADORA2B P29275 1/20 0.42
ADORA1 P30542 1/20 0.42
ADORA3 P0DMS8 1/20 0.42
MGAM O43451 1/20 0.41
GAA P10253 1/20 0.41
SI P14410 1/20 0.41
MGAM2 Q2M2H8 1/20 0.41
MAPT P10636 3/20 0.41
KMT2A Q03164 3/20 0.41
MCL1 Q07820 1/20 0.41
ALDH1A1 P00352 2/20 0.40
MEN1 O00255 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15944987 0.82 LPAR2 (0.55) SMN1; SMN2RAB9ANPC1GAAMAPT
SCHEMBL18106910 0.81 MAOB (0.45) SMN1; SMN2RAB9ANPC1MAOBADORA2A
SCHEMBL6118547 0.80 MAOB (0.65) SMN1; SMN2RAB9ANPC1IRAK4MAOB
SCHEMBL18106903 0.79 IRAK4 (0.62) SMN1; SMN2RAB9ANPC1IRAK4MAPT
SCHEMBL18106906 0.78 SMN1; SMN2 (0.63) SMN1; SMN2RAB9ANPC1MAOBADORA2A
SCHEMBL1013853 0.78 LMNA (0.54) SMN1; SMN2RAB9ANPC1IRAK4PKN1
SCHEMBL11020624 0.75 PKN1 (0.49) SMN1; SMN2RAB9ANPC1IRAK4PKN1
Nitric Acid SCHEMBL11577224 0.73 MGAM (0.48) SMN1; SMN2RAB9ANPC1IRAK4MAOB
SCHEMBL7478521 0.73 SMN1; SMN2 (0.47) SMN1; SMN2RAB9ANPC1IRAK4PKN1
SCHEMBL8601355 0.73 PKN1 (0.55) SMN1; SMN2RAB9ANPC1IRAK4PKN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2742029-B1 N-(BENZIMIMDAZOL-2-YL)-CYCLOPROPANE CARBOXAMIDES AS LYSOPHOSPHATIDIC ACID ANTAGONISTS MERCK PATENT GMBH (DE) 2016-10-05 EP claimed